You are here

Merck

Go or no go? Argenx's December showdown

EP Vantage

Wed, 12/1/21 - 10:10 am

myasthenia gravis

FDA panel narrowly recommends authorization of first antiviral pill to treat Covid-19

Stat

Tue, 11/30/21 - 11:35 pm

Ridgeback Biotherapeutics

Spinoff updates: Merck’s Organon and Novartis’ Sandoz

Generics and Biosimilar Initiative

Mon, 11/29/21 - 11:08 pm

New Merck study results raise questions about its COVID-19 pill

BioPharma Dive

Fri, 11/26/21 - 08:55 pm

Covid antivirals could be pandemic game-changers. But Americans might struggle to access them

Stat

Tue, 11/23/21 - 09:41 am

Merck pauses 'very important' HIV program after seeing red flag in phase 2 trial of once-weekly combo

Fierce Biotech

Fri, 11/19/21 - 10:54 am

clinical trials

Will Pfizer's COVID Pill Crush the Hopes of Merck Investors?

Motley Fool

Fri, 11/19/21 - 10:52 am

Merck's Keytruda scores first win in adjuvant kidney cancer, giving it a leg up on checkpoint inhibitor rivals

Endpoints

Thu, 11/18/21 - 10:37 am

adjuvant immunotherapy

renal cell carcinoma

Reports of smallpox vials found at Merck plant outside Philadelphia

Endpoints

Wed, 11/17/21 - 10:30 am

As Merck and Pfizer predict incoming billions from their COVID drugs, Roche culls pandemic ties with Atea

Fierce Biotech

Wed, 11/17/21 - 10:28 am

Atea Pharmaceuticals

Merck’s Anti-Cholesterol Drug Threatens Esperion, Other PCSK9 Inhibitor Makers

BioSpace

Mon, 11/15/21 - 11:55 pm

PCSK9 inhibitors

Merck looks to ditch the needles with its next-gen oral PCSK9 inhibitor for high cholesterol

Endpoints

Mon, 11/15/21 - 10:57 am

oral PCSK9 inhibitors

PCSK9 inhibitors

8 lingering questions about the new Covid pills from Merck and Pfizer

Stat

Mon, 11/15/21 - 10:38 am

Is Merck's Planned Acquisition of Acceleron in Trouble?

Motley Fool

Sat, 11/13/21 - 09:55 pm

Merck's COVID-19 antiviral pill vs. Pfizer's: What's the same, what's different

Beckers Hospital Review

Sat, 11/13/21 - 09:51 pm

Organon makes another women’s health move with deal for endometriosis-focused Forendo

MedCity News

Thu, 11/11/21 - 10:58 am

Merck inks yet another $1B-plus supply deal for COVID pill, this time with Japan

Fierce Pharma

Wed, 11/10/21 - 09:32 pm

US pays $1B to nearly double supply of Merck's COVID-19 pill

BioPharma Dive

Tue, 11/9/21 - 10:54 am

government contracts

Seeking an edge over Amgen, Mirati advances lower KRAS dose in Keytruda combo to improve tolerability

Fierce Biotech

Tue, 11/9/21 - 10:49 am

Mirati Therapeutics

clinical trials

Bristol Myers adds to neoadjuvant win for Opdivo in lung cancer, escalating early cancer showdown with Merck

Endpoints

Mon, 11/8/21 - 10:58 am

Bristol Myers Squibb

Pages